Figure 3.
Swimmer plot of treatment response to belantamab mafodotin. Patients who had previous exposure to BCMA-targeted therapies are marked with an asterisk. LOT, line of therapy; POD, progression of disease.
Swimmer plot of treatment response to belantamab mafodotin. Patients who had previous exposure to BCMA-targeted therapies are marked with an asterisk. LOT, line of therapy; POD, progression of disease.
